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Edited by Christian GriesingerAbstract We identiﬁed peroxiredoxin-4 (Prx-4) as a protein
interacting with the b isoform of the thromboxane A2 receptor
(TPb) by yeast two-hybrid analysis. Prx-4 co-immunoprecipi-
tated constitutively with TPb in HEK293 cells. The second and
third intracellular loops as well as the C-terminus of TPb inter-
acted directly with Prx-4. Co-expression of Prx-4 caused a 60%
decrease in cell surface expression of TPb. Prx-4 and TPb pre-
dominantly co-localized in the endoplasmic reticulum. Co-
expression of Prx-4 in cells treated with H2O2 targeted TPb
for degradation. We show for the ﬁrst time an interaction be-
tween a receptor involved in oxidative stress and Prx-4, an
anti-oxidative enzyme.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Thromboxane A2 (TXA2) is the sequential metabolic prod-
uct of arachidonic acid by the cyclooxygenases and thrombox-
ane synthase. The TXA2 receptor (TP) is a G protein-coupled
receptor (GPCR) that can couple to the G proteins Gaq, Gas,
Gai2, Ga12, Ga13, and Ga16[1]. The TP receptor is expressed as
two alternatively spliced isoforms, a (343 residues) and b (407
residues) that share the ﬁrst 328 residues[2,3].
Oxidative stress can be induced by diverse mechanisms,
including activation of TP [4,5]. A major product of peroxida-
tion is a group of compounds termed isoprostanes. Isopros-
tanes are mainly derived by free radical-mediated oxidation
of arachidonic acid [6]. The isoprostanes exert signiﬁcant bio-
logical activity and there is evidence that they interact with TP
[7–10].Abbreviations: GPCR, G protein-coupled receptor; TP, thromboxane
A2 receptor; TXA2, thromboxane A2; TPbCT, C-terminal tail of TPb;
GST, glutathione-S-transferase; GFP, green ﬂuorescent protein;
ELISA, enzyme-linked immunosorbent assay; HEK, human embry-
onic kidney; HA, hemagglutinin; ER, endoplasmic reticulum; ICL,
intracellular loop of the TPb receptor
*Corresponding author. Fax: +1 819 564 5265.
E-mail address: jean-luc.parent@usherbrooke.ca (J.-L. Parent).
1These authors contributed equally to this work.
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.07.011Peroxiredoxins (Prxs) have recently been the subject of
growing interest as a new family of thiol-speciﬁc antioxidant
proteins [11,12]. Prxs perform their protective antioxidant role
in cells through their peroxidase activity whereby hydrogen
peroxide, peroxynitrite and a wide range of organic hydroper-
oxides are reduced and detoxiﬁed [13]. At least six Prxs were
identiﬁed in mammalian cells (Prx1–Prx6). Prxs are ubiqui-
tously and abundantly expressed in the various tissues of the
human body [14] and were reported to be not redundant func-
tionally [15].
The data that we present here show that an anti-oxidant en-
zyme, Prx-4, can regulate the biology of TPb, a GPCR medi-
ating oxidative stress.2. Materials and methods
2.1. Materials
The HA- and Myc-speciﬁc monoclonal antibodies were from Cov-
ance. The rabbit anti-calnexin A polyclonal antibody was acquired
from Sigma. The Cascade Blue goat anti-mouse, goat anti-rabbit Texas
Red, and ﬂuorescein isothiocyanate (FITC)-conjugated goat anti-
mouse antibodies were purchased from Molecular Probes. The goat
anti-mouse alkaline-phosphatase-conjugated antibody and the alkaline
phosphatase substrate kit were obtained from Bio-Rad. U46619 was
from Cayman.2.2. Two-hybrid screening assay
Yeast two-hybrid screening was performed with the C-terminus of
TPb as a bait on a Human HeLa MATCHMAKER cDNA Library
(Clontech) as we described previously [16].2.3. Cell culture and transfection
HEK293 cells were maintained and transfected as detailed before
[16].2.4. Immunoprecipitations
6-Well plates of HEK293 cells were transfected with the indicated
combinations of constructs. Transfected cells were maintained for
48 h and incubated for 0–30 min at 37 C in the presence of 1 lM
U46619 prior to harvesting. Thereafter, the cells were processed for
immunoprecipitations as we reported previously [16].2.5. Recombinant protein production and binding assays
A pRSET A-myc-Prx-4 construct was used to produce a His-tagged
myc-Prx-4 fusion protein in OverExpress C41(DE3) Escherichia coli
strain (Avidis, SA) by following the manufacturer’s instructions. Ami-
no acids 53–66 (ICL1), 129–150 (ICL2), 217–244 (ICL3), and 312–407
(C-tail) were produced as fusion proteins with glutathione-S-transfer-
ase (GST) and the pulldown assays performed as we described before
[17].blished by Elsevier B.V. All rights reserved.
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Inositol phosphates measurements were carried out as we detailed
previously [18].2.7. Endocytosis and cell surface expression assays
Endocytosis and cell surface expression of receptors was measured
by enzyme-linked immunosorbent assay (ELISA) using transiently
transfected HEK293 cells as we previously reported [17].2.8. Immunoﬂuorescence microscopy
1.0 · 106 HEK293 cells were transiently co-transfected with the
pcDNA3-HA-TPb green ﬂuorescent protein (GFP) [19] and
pcDNA3-myc-Prx-4 constructs and maintained overnight.The cells
were then processed for immunoﬂuorescence microscopy as we de-
tailed before on a Nikon Eclipse TE2000-U microscope using a 60·
objective, and images were collected using SimplePCI Camera software
and processed with Adobe Photoshop software [17].3. Results and discussion
3.1. Prx-4 interacts with TPb
We recently showed that the C-terminus conferred speciﬁc
regulatory mechanisms to TPb [20,21]. In our eﬀorts to eluci-
date the mechanisms involved in the regulation of TPb, we per-
formed yeast two-hybrid screening experiments using the yeast
strain pJ69-4a transformed with pAS2.1-TPbCT and a human
HeLa cell cDNA library. A total of 1.5 · 106 independent
clones were screened yielding over 300 positives. One hundred
clones demonstrating a strong growth on selective yeast med-
ium (TRP, LEU, HIS, and ADE) were then isolated
and characterized by dideoxy sequencing, and then aligned
using the NCBI blast alignment search tool. Four clones con-
tained a cDNA fragment coding for the Prx-4 protein. Other
members of the Prx protein family were not isolated in the
clones that were sequenced.Fig. 1. Prx-4 co-immunoprecipitates with TPb. HEK293 cells were
transiently transfected with the indicated constructs. Forty-eight hours
post-transfection, the cells were stimulated or not with 1 lM U46619,
lysed and processed for immunoprecipitation of the receptor with a
HA-speciﬁc polyclonal antibody. Immunoblotting was performed with
HA-speciﬁc polyclonal or Myc-speciﬁc monoclonal antibodies as
described in Section 2. Data presented are representative of three
diﬀerent experiments. IP, immunoprecipitation; IB, immunoblotting.3.2. Co-immunoprecipitations and in vitro binding assay
To investigate the interaction of Prx-4 with TPb in a cellular
context, we performed immunoprecipitation experiments in
HEK293 cells transfected with pcDNA3-Myc-Prx-4 and
pcDNA3-HA-TPb in the presence or absence of stimulation
with the stable TP receptor agonist, U46619. Our results dem-
onstrate that Myc-Prx-4 was co-immunoprecipitated with TPb
in absence of agonist (Fig. 1). Agonist treatment did not mod-
ulate the interaction between the two proteins (Fig. 1). To fur-
ther characterize the interaction of Prx-4 with the TPb
receptor, we carried out an in vitro binding assay using the
puriﬁed recombinant intracellular loop 1 (ICL1), ICL2,
ICL3, or C-tail (CT) of TPb fused to GST along with puriﬁed
His6-Myc-Prx-4 protein. A schematic representation of the
TPb topology is illustrated in Fig. 2A. The results showed that
Prx-4 interacted speciﬁcally with glutathione sepharose-bound
GST-TPb-ICL2, -ICL3, and -CT but not with glutathione se-
pharose-bound GST or GST-TPb-ICL1 (Fig. 2B). Taken to-
gether, our data show that Prx-4 interacts directly with
intracellular domains of TPb, predominantly with the C-tail,
in an agonist-independent manner. Interestingly, this consti-Fig. 2. Prx-4 directly interacts with intracellular domains of TPb. (A)
Schematic representation of the topology of TPb. The receptor is
composed of seven transmembrane domains connected by three
extracellular and three intracellular loops. The C-terminus completes
the intracellular domains of the receptor. The numbers indicate the
ﬁrst and the last of the amino acids for each intracellular domain that
were used to produce fusion proteins with GST. (B) The intracellular
loops 1–3 (ICL1, ICL2, and ICL3) and the C-tail of the receptor were
produced as GST-fusion proteins and used to perform GST-pulldown
assays on puriﬁed His6-Prx-4myc protein. The upper panel shows the
Prx-4 binding to the receptor domains, while the GST-fusion proteins
present in the reaction can be seen in the middle panel. The bottom
panel shows the level of Prx-4 protein present in the initial reaction.
Data presented are representative of three diﬀerent experiments. IB,
immunoblotting.
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tein with a G protein-coupled receptor, and to our knowledge
to any transmembrane receptor, is shown.
3.3. Regulation of TPb receptor signaling by Prx-4
Members of the Prx protein family have been shown to reg-
ulate the signaling of various classes of receptors, including the
receptors for EGF, PDGF, and TNFa (reviewed in Ref. [23]).
We thus assessed if Prx-4 could modulate the generation of
inositol phosphates by TPb following agonist stimulation.
Fig. 3A illustrates that co-expression of Prx-4 with the receptor
in HEK293 cells resulted in a 70% inhibition of receptor-
mediated production of inositol phosphates following agonist
treatment when compared to cells expressing the receptor
alone. Production of inositol phosphates by a Gaq-coupled
receptor involves the receptor-Gaq interaction and activation
of the G protein, with subsequent stimulation of phospholi-
pase Cb by the activated Gaq. Interestingly, Prx-4 overexpres-
sion did not aﬀect the generation of inositol phosphates by a
constitutive mutant of Gaq, Gaq-R183C (Fig. 3B). This indi-
cated that Prx-4 was not acting at the level of the phospholi-
pase Cb activation by Gaq, but rather at the level of the
receptor itself. Co-immunoprecipitation experiments demon-
strated that the TPb receptor-Gaq interaction was not pre-Fig. 3. Regulation of TPb signaling by Prx-4. HEK293 cells were
transiently co-transfected with the indicated constructs and labelled
with 3H-myo-inositol. Total inositol phosphates were measured after
treatment of the cells with 500 nM U46619 for 30 min (A) or after
30 min of accumulation in presence of the constitutive Gq-R183C
mutant (B) as described in Section 2. Results are means ± S.E. from
ﬁve diﬀerent experiments.vented by co-expression of Prx-4 (data not shown). Thus,
this suggested that Prx-4 was acting on the receptor to suppress
its signaling but not by interfering with its interaction with the
Gaq protein.
3.4. Regulation of TPb cell surface expression by Prx-4
Since the response of a cell surface receptor to an agonist is
controlled in part by the number of receptors present at the
plasma membrane, we next studied whether Prx-4 could alter
the internalization and/or the cell surface expression of TPb.
HEK293 cells expressing HA-tagged TPb alone or in combina-
tion with Prx-4 were stimulated with 100 nM U46619 or etha-
nol (vehicle) for 120 min and receptors present at the cell
surface measured by ELISA, as we did before [16,19–21].
Prx-4 expression had no eﬀect on internalization of the recep-
tor (Fig. 4A). On the other hand, the expression of TPb at the
cell surface was reduced by roughly 60% when Prx-4 was pres-
ent (Fig. 4B), which is most likely the cause of the reduced
receptor-mediated signaling after agonist treatment.
3.5. TPb and Prx-4 co-localize intracellularly
Given that our results suggested that Prx-4 inhibited the cell
surface expression of TPb, we were interested in determining if
and where the two proteins co-localized in the cell. Fluores-
cence microscopy experiments were performed on HEK293
cells co-expressing GFP-tagged TPb [19] and Myc-Prx-4. Ini-
tial experiments showed that the two proteins co-localized in
an intracellular compartment that could be the endoplas-
mic reticulum (ER). Three-color ﬂuorescence microscopy,Fig. 4. Prx-4 overexpression inhibits TPb cell surface expression.
HEK293 cells were transiently co-transfected with the HA-tagged TPb
and pcDNA3 or pcDNA3-Prx-4myc. The percentage of cell surface
receptor loss following a 2 h stimulation with 100 nM U46619 (A) or
cell surface expression (B) was measured by ELISA as described in
Section 2. Results are means ± S.E. from six diﬀerent experiments.
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out. The receptor and Prx-4 co-localized intracellularly in
absence of agonist stimulation, as shown in Fig. 5. Agonist
treatment failed to signiﬁcantly change the intracellular co-
localization pattern of both proteins. We observed that co-
localization of TPb (green) with Prx-4 (purple) occurred for
the major part in the ER (red), as indicated by the white-colored
region (Fig. 5). Co-localization of the receptor with Prx-4 also
appeared in some cells in a compartment reminiscent of the
Golgi (data not shown). We have previously demonstrated that
the traﬃcking of TPb present at the cell surface can be followed
by immunoﬂuorescence microscopy by labelling the receptor
with an anti-HA antibody at 16 C prior to constitutive or ago-Fig. 5. Prx-4 and TPb co-localize in the endoplasmic reticulum. HEK293
processed for immunoﬂuorescence microscopy on an inverted Nikon Eclipse
were visualized with mouse monoclonal anti-Myc and rabbit polyclonal anti-
goat anti-rabbit Texas Red-conjugated antibodies, respectively. The recepto
localization of the three proteins is detected by the presence of white color.nist-induced internalization of the receptor at 37 C [20,21].
TPb traﬃcking from the cell surface was never found to co-
localize with Prx-4 (Fig. 6). Interestingly, these results indicate
that TPb and Prx-4 interact intracellularly, predominantly at
the ER, during synthesis/maturation of the receptor protein,
and not during the internalization and recycling of the receptor
from and back to the cell surface, respectively.
3.6. Prx-4 targets TPb for degradation during oxidative stress
Proteins accumulating at the ER can be targeted to the
ERAD (endoplasmic reticulum-associated degradation), which
employs a series of processes leading to protein degradation by
the proteasome pathway. Of relevance to our study, thecells transiently co-expressing GFP-tagged TPb and Prx-4myc were
TE-2000 microscope as described in Section 2. Prx-4 and calnexin A
calnexin A antibodies, followed by goat anti-mouse Cascade Blue- and
r is thus seen in green, Prx-4 in purple, and calnexin A in red. Co-
Results are representative of three independent experiments.
Fig. 6. Cell surface TPb do not co-localize with Prx-4 after agonist-
induced endocytosis. HEK293 cells were co-transfected with pcDNA3-
HA-tagged TPb and pcDNA3-Prx-4myc. Cell surface receptors were
labelled with a monoclonal anti-HA antibody prior to stimulating the
cells with 100 nM U46619 for 60 min, as we detailed before [20,21].
The cells were then processed for immunoﬂuorescence microscopy
with a polyclonal anti-myc antibody, followed by incubation with goat
anti-mouse ﬂuorescein- and goat anti-rabbit Texas-Red-conjugated
antibodies. The receptors are seen in green while Prx-4 is visualized in
red. Results are representative of three separate experiments.
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[22]. Because Prx-4 co-localized with TPb at the ER and inhib-Fig. 7. Co-expression of Prx-4 targets TPb for degradation during oxidative
treated with 1 lMH2O2 or H2O (vehicle) for diﬀerent time intervals. Levels of
a monoclonal anti-HA Ab. H2O2 triggers receptor degradation of the recept
eﬀect on receptor protein levels in presence of Prx-4. Results are representatited its cell surface expression, we went on to verify if Prx-4
could modulate the level of receptor protein during oxidative
stress. HEK293 cells expressing the HA-tagged receptor alone
or in combination with Myc-Prx4 were treated with 10 lM
H2O2 or with H2O (vehicle) for diﬀerent time intervals. The
cells were then lysed and TPb protein levels determined by
Western blots. Stimulation of the cells with H2O2 did not aﬀect
the TPb-Prx-4 co-immunoprecipitation (data not shown). It
can be seen in Fig. 7 that treatment of the cells with H2O (vehi-
cle) had no signiﬁcant eﬀect on levels of receptor protein. The
addition of H2O2 to cells expressing the receptor alone caused
a small reduction in the amount of receptor protein detected in
the cell lysates. Surprisingly, co-expression of Prx-4 largely re-
duced the total amount of detectable TPb protein in the cell ly-
sates after 180 min of H2O2 treatment, indicating that Prx-4
targets the receptor to degradation during oxidative stress.
Prxs are ubiquitously and abundantly expressed in the vari-
ous tissues of the human body [14]. These enzymes are pro-
duced at high levels in cells: they are the second or third
most abundant protein in erythrocytes and compose 0.1–
0.8% of the soluble protein in other mammalian cells [11].
Many organisms produce more than one isoform of Prx,
including at least six Prxs identiﬁed in mammalian cells (Prx-
1 to Prx-6). Although located primarily in the cytosol, Prxs
are also found within mitochondria and peroxisomes, and
associated with nuclei and membranes [13]. Prxs contain a
reactive Cys in a conserved region near the N-terminus, and
this catalytic Cys residue forms cysteine-sulfenic acid as a reac-
tion intermediate during the reduction of peroxide. All the
Prxs exhibit peroxidase activity dependent on reduced forms
of thioredoxin and/or glutathione. Prx-1–Prx-4 have an addi-
tional Cys at a conserved position near the C-terminus. Prx-
1–Prx-4 are cross members of the same family and form astress. HEK293 cells co-transfected with the indicated constructs were
receptor proteins were detected in cell lysates by Western blotting with
or only when Prx-4 is co-expressed. Treatment with the vehicle had no
ive of four independent experiments.
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are monomeric and presumed to be far from the other Prxs
from an evolutionary point of view [24]. Prxs are not redun-
dant functionally [15]. In this context, it is interesting to note
that only Prx-4 was pulled out as a speciﬁc interacting partner
of TPb by the yeast two-hybrid screen. Further experiments
will substantiate whether TPb interacts with the other isoforms
of the Prxs in a cellular context.
Oxidative stress in blood vessels and the kidney can be in-
duced by diverse mechanisms, including activation of the TP
receptor [4,5]. The study of the involvement of Prxs in receptor
signaling has received considerable attention in the recent
years. It was shown that Prx-1 and Prx-2 inhibit EGF- and
PDGF-induced H2O2 generation [reviewed in 23]. These and
other studies showed that Prxs also suppress downstream sig-
naling responses of receptors, such as apoptosis, NF-kB tran-
scriptional and JNK activities [23]. However, there is a lack of
information regarding a direct mechanism by which Prxs inﬂu-
ence receptor-mediated signaling. Here we report for the ﬁrst
time that an anti-oxidant enzyme, Prx-4, interacts with and
regulates a pro-oxidant receptor, TPb. This interaction may
correspond to one mechanism by which a cell could cope with
oxidative stress. By interacting intracellularly with a receptor,
Prx-4 could limit the responsiveness of the receptor involved in
generating oxidative stress by regulating its cell surface expres-
sion. Moreover, Prx-4 could put a stop to an ampliﬁcation
loop by targeting the receptor for degradation during oxidative
stress.
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